Route Mobile Ltd

Route Mobile Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Route Mobile Ltd

₹ 1,389 -1.80%
21 Nov - close price
routemobile.com BSE: 543228 NSE: ROUTE
About

Route Mobile Limited is a cloud communications platform service provider catering to enterprises, OTT players, and mobile network operators (MNOs). RML's portfolio comprises solutions in Business Messaging, Voice, Email, SMS filtering, analytics, and monetization.[1]
Route Mobile Became a part of Proximus Group in May'24[2]

Key Points

Business Segments[1]
Enterprise and OTT: Provides cloud based communication platform to enterprises to enable digital communication through multiple channels including RCS, A2P / P2A messaging, 2Way Messaging, etc,.
Mobile Operator: Main service offerings in this segment include SMS analytics, firewall, filtering, monetization and CPaaS and hubbing solutions
Digital Identity & Security Services:Co. launched TruSense, a digital identity and security suite that secures digital transactions through a reliable ecosystem, enabling businesses to authenticate the end user in a frictionless way.
Business Process Outsourcing: They provide client support, technical support, booking and collection services

Website BSE NSE
  • Market Cap ₹ 8,758 Cr.
  • Current Price ₹ 1,389
  • High / Low ₹ 1,942 / 1,334
  • Stock P/E 24.6
  • Book Value ₹ 372
  • Dividend Yield 0.79 %
  • ROCE 20.7 %
  • ROE 18.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 45.5% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 19.4%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: IT - Software Industry: Computers - Software - Medium / Small

Part of BSE 250 SmallCap Index Nifty Smallcap 250 BSE Allcap BSE Telecommunication Nifty 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
436 563 626 729 846 986 1,009 967 1,015 1,024 1,017 1,103 1,113
380 502 570 644 743 861 877 840 886 899 892 980 978
Operating Profit 56 61 56 85 103 125 132 127 128 125 125 124 135
OPM % 13% 11% 9% 12% 12% 13% 13% 13% 13% 12% 12% 11% 12%
2 5 8 15 2 8 15 11 4 35 13 11 39
Interest 1 1 3 4 4 7 5 7 7 6 8 9 14
Depreciation 7 10 15 20 19 22 21 21 21 22 22 22 22
Profit before tax 50 55 47 76 82 103 120 110 104 132 109 103 137
Tax % 17% 16% -1% 6% 12% 17% 14% 17% 15% 14% 13% 21% 22%
42 46 47 71 73 85 104 92 88 114 95 81 107
EPS in Rs 7.28 7.08 7.25 11.01 11.84 13.23 16.27 14.80 14.18 16.89 14.03 12.51 16.08
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
367 458 505 845 956 1,406 2,002 3,569 4,023 4,258
288 375 433 758 855 1,231 1,782 3,124 3,510 3,749
Operating Profit 80 82 72 87 101 175 220 445 514 510
OPM % 22% 18% 14% 10% 11% 12% 11% 12% 13% 12%
4 5 5 8 -3 16 20 39 57 97
Interest 1 1 7 12 6 4 7 22 30 38
Depreciation 3 5 12 17 23 26 38 82 86 88
Profit before tax 80 81 57 65 69 162 195 382 455 481
Tax % 22% 25% 17% 15% 16% 18% 13% 13% 15%
63 61 48 56 58 133 170 333 389 397
EPS in Rs 31.37 12.13 9.74 11.38 11.65 23.10 26.36 52.38 59.74 59.51
Dividend Payout % 35% 0% 15% 13% 13% 9% 19% 21% 18%
Compounded Sales Growth
10 Years: %
5 Years: 37%
3 Years: 42%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: 45%
3 Years: 40%
TTM: -2%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -9%
1 Year: -10%
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 17%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 20 50 50 50 50 58 63 62 63 63
Reserves 50 77 121 173 219 594 1,610 1,758 2,087 2,279
0 18 84 79 53 20 16 140 378 564
158 55 168 185 302 350 964 916 934 875
Total Liabilities 228 200 423 487 625 1,022 2,653 2,877 3,462 3,781
9 33 182 170 176 193 952 953 898 888
CWIP 1 0 0 2 0 1 0 15 26 1
Investments 0 0 0 11 12 13 13 20 15 15
218 167 241 304 438 815 1,688 1,889 2,523 2,877
Total Assets 228 200 423 487 625 1,022 2,653 2,877 3,462 3,781

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
203 -60 28 23 98 222 135 73 -98
-35 -19 -132 0 1 -225 -821 111 -2
-33 18 46 -17 -67 211 824 -108 158
Net Cash Flow 135 -61 -57 6 32 208 137 76 59

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 22 26 70 63 78 56 94 72 97
Inventory Days 0 0 0 0 0 0 0 0 0
Days Payable
Cash Conversion Cycle 22 26 70 63 78 56 94 72 97
Working Capital Days -130 -14 -37 -5 -5 -16 -5 18 50
ROCE % 76% 32% 28% 29% 33% 17% 22% 21%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
59.98% 59.82% 59.82% 58.56% 58.43% 58.32% 58.32% 58.15% 58.15% 57.99% 83.11% 74.90%
19.80% 20.15% 19.94% 21.32% 21.11% 20.30% 21.34% 21.76% 21.59% 15.83% 5.75% 6.65%
6.65% 5.80% 7.03% 7.18% 7.21% 8.15% 6.81% 5.50% 5.99% 5.83% 1.04% 6.14%
13.56% 13.95% 13.21% 12.94% 13.23% 13.25% 13.53% 14.56% 14.26% 20.35% 10.10% 12.29%
0.00% 0.27% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
No. of Shareholders 1,89,0072,09,6262,22,1522,22,0942,21,2302,18,9912,10,4911,94,9871,84,0601,75,5491,48,7211,51,020

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls